Tomorrow February 4th is World Cancer Day, a global health awareness day. World Cancer Day aims to prevent millions of deaths by raising awareness about cancer and taking action against the disease.
Aidian offers effective solutions for cancer diagnostics
Colorectal cancer (CRC) is the third most common cancer and the second most common cancer-related cause of death worldwide1. Early detection of CRC or its precursors significantly improves the chance for survival and screening programmes have been shown to reduce both CRC incidence and mortality2.
QuikRead go® iFOBT is a faecal immunochemical test (FIT) for the detection and quantification of hemoglobin (Hb) in faeces. Instrument-read result is ready already within 3 minutes. The test can be used in routine physical examinations and in screening programmes for CRC.
Read more about QuikRead go iFOBT.
Bladder cancer is the 10th most common cancer worldwide and the 5th most common cancer in the western world1. Bladder EpiCheck provides patients and clinicians with a simple, non-invasive and accurate urine test to detect recurrence of bladder tumors. The test analyzes subtle disease-specific changes in DNA methylation markers, allowing for the detection of 91% of the high-risk cancers. Bladder EpiCheck is approved for the diagnosis and surveillance of both UTUC and NMIBC. Aidian distributes Bladder EpiCheck in the Nordics.
Read more about Bladder EpiCheck:
Contact us at Aidian to hear more about these products.
- World Health Organization. Global Cancer Observatory database. https://gco.iarc.fr/. Accessed 2.2.2023
- European commission. European guidelines for quality assurance in colorectal cancer screening and diagnosis – First Edition. Segnan N, Patrick J, von Karsa L (eds.), 2010.